Clinical Trial Update: Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-302) [Phase 3]

View source ↗

Summary

Phase 3 trial AR882-302 evaluating AR882 for gout is currently active but not recruiting, with no efficacy or safety results reported in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Gouty Arthritis
• Hyperuricemia

Drugs mentioned

• AR882

Snippet

Sponsor: Arthrosi Therapeutics | Conditions: Gout, Arthritis, Gouty | Phase 3 | Status: ACTIVE_NOT_RECRUITING